President Joe Biden’s ability to “f*ck things up” has come to the fore yet again as his “Cancer Moonshot” left treatment centers counting on China to alleviate shortages.

(Video: Fox 5)

After the nonprofit Biden Cancer Initiative was found to have contributed the bulk of the millions raised toward “salaries, compensation, and benefits” to executives along with the costs of meetings, never once funding a grant for research, the president re-upped his “commitment” with a goal to cut cancer deaths in half in 25 years.

Aiming “to turn more cancers from death sentences into chronic diseases people can live with,” as Biden promised in September, has now left more than 90 percent of cancer centers monitored by the National Comprehensive Cancer Network (NCCN) experiencing a shortage of primary cancer-fighting drugs Carboplatin and Cisplatin.

Speaking with Fox News, NCCN CEO Dr. Robert W. Carlson said, “Some of the facilities in the United States, we understand, actually have no Carboplatin or Cisplatin available.”

“It’s going to get worse before it gets better,” he continued and suggested, “The current estimates are that up to 500,000 cancer patients per year could be affected by the shortage of these two agents.”

Earlier this month, NCCN released a statement on the shortages and found that of the 27 U.S. cancer centers surveyed, 93 percent were short on Carboplatin and 70 percent were short on Cisplatin, both platinum-based chemotherapy drugs commonly used to eliminate stage 1, 2, or 3 cancers like lung and testicular.

“This is an unacceptable situation. We are hearing from oncologists and pharmacists across the country who have to scramble to find appropriate alternatives for treating their patients with cancer right now,” Carlson said in the statement. “We were relieved by survey results that show patients are still able to get life-saving care, but it comes at a burden to our overtaxed medical facilities. We need to work together to improve the current situation and prevent it from happening again in the future.”

Like other shortages experienced during the current administration, such as the baby formula shortage, warnings appeared to fall on deaf ears as supply-chain issues coupled with post-COVID increased demand for certain medications have impacted availability. Cisplatin manufacturers had suggested relief would arrive by June, but the outlook remains bleak.

Doctors issue dire warning to cancer patients amid ‘historical’ shortage of life-saving drugshttps://t.co/EacizyaSJe

— American Wire News (@americanwire_) April 12, 2023

“I was worried because I didn’t want this to be prolonged,” North Carolina stage 2 lung cancer patient Gail Lass told Fox News after her doctor couldn’t acquire her necessary drugs. Fortunately, they were able to provide them at a nearby hospital where Dr. Justin Favaro, hematologist and oncologist at Oncology Specialists of Charlotte, said. “Usually, one of us can get the drug, but it’s just become more of a challenge.”

Now, the U.S. Food and Drug Administration (FDA) is turning toward Chinese drug manufacturers to resolve the shortages, telling Fox News in a statement, “The FDA recognizes the potential impact that lack of availability of certain products may have on health care providers and patients.”

“While the agency does not manufacture drugs and cannot require a pharmaceutical company to make a drug, make more of a drug, or change the distribution of a drug, the public should rest assured the FDA is working closely with numerous manufacturers and others in the supply chain to understand, mitigate and prevent or reduce the impact of intermittent or reduced availability of certain products,” the agency claimed.

Welcome to Bidens New Normal.

— Jerry Cheesbro (@CheesbroJerry) June 20, 2023

But joe biden promised to cure cancer

— cbz (@cbz3000000) June 20, 2023

Thank Biden

— Meredith (@Meredith5162) June 20, 2023

• About
• Latest Posts

Kevin Haggerty

Staff Writer

Native of Brooklyn, NY, Kevin Haggerty is a graduate of Hunter College where he studied Cultural Anthropology and Geography. An avid reader and truth seeker, he currently resides in Texas with his wife and their dog and, when he isn't researching current events and their impacts, you'll find him spending time with friends and family or working on his next novel.

Latest posts by Kevin Haggerty (see all)

• Rogan fired up that liberal policies are allowing monsters to eat our house pets - December 17, 2025
• Customer bullies Target employee over Charlie Kirk shirt, but it doesn’t go quite as planned - December 17, 2025
• Merrick Garland lied about Mar-a-Lago raid recently declassified emails show - December 17, 2025

Comment

We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. Thank you for partnering with us to maintain fruitful conversation.